Paradigm Biopharmaceuticals stock forecast
Paradigm Biopharmaceuticals (PBIGF) Stock Forecast & Price Target
PBIGF Analyst Ratings
PBIGF Stock 12 Month Forecast
Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| John Hester | Bell Potter | $0.31→$0.29 | buy | 2545.18%Upside | Reiterated | 08/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| John HesterBell Potter | BuyReiterated$0.31→$0.29 | 08/03/26 | 2545.18%Upside |
Best Analysts Covering Paradigm Biopharmaceuticals
Copying John Hester's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +4.94% per trade.
Copying John Hester's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -38.92% per trade.
Copying John Hester's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -75.85% per trade.
PBIGF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 2 | 1 | 1 | 0 |
In the current month, PBIGF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PBIGF average Analyst price target in the past 3 months is ―.
PBIGF Financial Forecast
PBIGF Earnings Forecast
Next quarter’s earnings estimate for PBIGF is -$0.07 with a range of ― to ―. The previous quarter’s EPS was -$0.07. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
PBIGF Sales Forecast
Next quarter’s sales forecast for PBIGF is $39.37K with a range of ― to ―. The previous quarter’s sales results were $39.37K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
